Cytochrome P450 (CYP450) Variant Genotyping (e.g., CYP2D6, CYP2C9, CYP2C19, CYP1A2, CYP3A4)
|
Re-Reviewed
|
02/18/2019 |
Investigative and therefore not covered
|
No change in determination
|
Exhaled Breath Tests for Asthma and Other Inflammatory Pulmonary Conditions: Exhaled Nitric Oxide Breath Test and Exhaled Breath Condensate pH Measurement |
Re-Reviewed |
02/18/2019 |
Covered for some indications; investigative and therefore not covered for all other indications |
No change in determination |
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Immunoassay for Prediction of Risk for Coronary Heart Disease or Ischemic Stroke (PLAC® Test) |
Re-Reviewed |
02/18/2019 |
Investigative and therefore not covered |
No change in determination
|
Lipoprotein Subclass Testing for Screening, Evaluation, and Monitoring of Cardiovascular Disease |
Re-Reviewed |
02/18/2019 |
Investigative and therefore not covered |
No change in determination |
Multichannel Intraluminal Esophageal Impedance with pH Monitoring |
Re-Reviewed |
12/19/2018
Enhanced benefit
|
Covered for some indications; investigative and therefore not covered for all other indications |
Change in determination:
- Not investigative for the evaluation of gastroesophageal reflux disease (GERD) in individuals non-responsive to treatment or with atypical symptoms.
- Investigative for all other indications.
|
Quantitative Electroencephalogram (qEEG) and Referenced Electroencephalogram (rEEG) |
Re-Reviewed |
02/18/2019 |
Covered for some indications; investigative and therefore not covered for all other indications |
No change in determination
|
Transcatheter Heart Valve Replacement and Repair Procedures
|
Re-Reviewed |
02/18/2019 |
Covered for some indications; investigative and therefore not covered for all other indications |
No change in determination
|